New Leaf Biopharma Opportunities II, L.P. insider trades: Harpoon Therapeutics (HARP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where New Leaf Biopharma Opportunities II, L.P. reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 11, 2021 | HARP | ↑ Buy | 235,294 | $17.00 | $4.0M | Indirect | Aug 12, 2021 (213d) |
| Aug 13, 2019 | PRNB | ↓ Sell | 300,000 | $35.00 | $10.5M | Indirect | Aug 15, 2019 (2d) |
| Feb 12, 2019 | HARP | ↑ Buy | 428,571 | $14.00 | $6.0M | Indirect | Feb 14, 2019 (2d) |
| Sep 18, 2018 | PRNB | ↑ Buy | 270,000 | $17.00 | $4.6M | Indirect | Sep 20, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About New Leaf Biopharma Opportunities II, L.P.'s insider trades
New Leaf Biopharma Opportunities II, L.P. is an insider at Harpoon Therapeutics (HARP). Since Sep 18, 2018, it has reported 3 open-market purchases worth $14.6M and 1 sale worth $10.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (2 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HARP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.